Antibody-Nanoparticle Conjugates
ID: 1301172257Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE NAVYNAVAL MEDICAL RESEARCH CENTERSILVER SPRING, MD, 20910-7500, USA

NAICS

Colleges, Universities, and Professional Schools (611310)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/6891eef878644f82b953a96332c3f9ef/view
Timeline
    Description

    The Department of Defense, through the Naval Medical Research Center (NMRC), intends to award a sole-source contract to the University of Chicago for the development and delivery of specialized antibody-nanoparticle conjugates aimed at inhibiting dengue virus infection. The contract, valued at $50,000, will leverage Dr. Huang's unique research capabilities to produce engineered photothermal nanoparticles with antiviral properties, which are not commercially available and require complex development processes. This procurement is justified under federal regulations due to the specific expertise of the University of Chicago, with no alternative vendors identified during market research. Interested parties may contact Ms. Vania Harrison at priscilla.v.harrison.civ@health.mil or call 240-507-9229 within 15 calendar days of this notice for further information.

    Point(s) of Contact
    Ms. Vania Harrison
    (240) 507-9229
    priscilla.v.harrison.civ@health.mil
    Files
    Title
    Posted
    ANC UoC J and A_..pdf
    The Naval Medical Research Command (NMRC) seeks to acquire services from the University of Chicago for the development and delivery of specialized antibody-nanoparticle conjugates aimed at targeting and killing the dengue virus. This one-year contract, valued at $50,000, will leverage Dr. Huang’s research to create engineered photothermal nanoparticles that possess antiviral properties. The unique capabilities of Dr. Huang's lab are critical, as these nanoparticle products are not commercially available, and involve complex processes beyond typical nanoparticle development. The justification for this sole-source acquisition cites federal regulations permitting it, specifically 10 U.S.C. 2304(c)(1) and FAR 13.106-1(b)(1), due to the specific expertise and unique qualifications of the University of Chicago. An extensive market survey confirmed the absence of alternative vendors capable of fulfilling this specific requirement, with no viable responses from contacted potential suppliers. This request is positioned as a one-time purchase, with no immediate plans for future competitive solicitations, though NMRC will remain open to new sources if they arise. The Contracting Officer will ensure the projected costs are fair and reasonable through thorough price analysis before awarding the contract.
    Lifecycle
    Title
    Type
    Antibody-Nanoparticle Conjugates
    Currently viewing
    Presolicitation
    Similar Opportunities
    Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to award a sole source contract for the procurement of Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody UB-421, with a requirement of 100 liters. This procurement is critical for an ongoing clinical trial aimed at treating patients with multidrug-resistant HIV-1 infection, utilizing UB-421, which is exclusively manufactured by United BioPharma, Inc., the sole patent holder and provider of the necessary cell line for production. Interested parties who believe they can meet the specifications must submit a capability statement to the primary contact, Hershea Vance, by 3:00 PM EST on September 20, 2024, as the contract is expected to be awarded within 19 days of this notice, with a performance period from September 23, 2024, to September 24, 2025.
    Luminex 200
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Submarine Medical Research Laboratory (NSMRL), is seeking proposals for the procurement of a Luminex 200 Instrument System, which is essential for conducting antibody and RNA transcript analyses. This advanced analytical equipment will enable NSMRL to perform in-house biochemical analyses, facilitating the simultaneous detection of multiple proteins and gene expression, thereby improving the health and performance of Navy divers and submariners by addressing risks associated with oxygen toxicity and decompression stress. Interested contractors must submit their proposals by 8:00 AM on September 20, 2024, including detailed pricing and compliance with federal regulations, with a total funding amount of $63,000 for this sole source procurement from Thermofisher Scientific. For further inquiries, interested parties should contact Jessica Lindner at jessica.c.lindner2.civ@us.navy.mil.
    Hitachi HT7800 Transmission Electron Microscope
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for the procurement of a Hitachi HT7800 Transmission Electron Microscope. This acquisition aims to support the development of antibody therapeutics and the design of vaccines and antivirals, which are critical for ongoing research at the Vaccine Research Center (VRC). The procurement is governed by FAR Simplified Acquisition Procedures, and the selected vendor will be required to deliver the microscope within 30 days of award, with installation and training to be completed by March 25, 2024. Interested vendors must submit their quotes by 12:00 PM EST on September 23, 2024, to Hershea Vance at hershea.vance@nih.gov, and ensure compliance with all specified requirements and clauses outlined in the solicitation.
    FLS1000-SS-stm Steady State, Phosphorescence Lifetime and Fluorescence Lifetime Spectrometer
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEPT OF THE NAVY is planning to procure a FLS1000-SS-stm Steady State, Phosphorescence Lifetime and Fluorescence Lifetime Spectrometer. This laboratory equipment and supplies item will be used for research purposes at the Naval Research Laboratory in Washington, DC (zip code: 20375), USA. The procurement will be a sole source purchase order awarded to EDINBURGH INSTRUMENTS of FULTON, MD. Interested parties have 3 calendar days to express their interest and capability to respond to this requirement. The purchase will be made utilizing Simplified Acquisition Procedures in accordance with Federal Acquisition Regulation (FAR) Part 13.106-1(b) for purchases not exceeding the simplified acquisition threshold of $250,000. The primary contact for this procurement is James Chappell, reachable at james.chappell@nrl.navy.mil or 2029231418. Please reference the Notice of Intent number, N00173-24-Q-1301102867, in any correspondence.
    Surface Plasmon Resonance (SPR) Instrument- Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for a Surface Plasmon Resonance (SPR) Instrument, either brand name or equal, to support its Vaccine Research Center's structural biology efforts. The procurement aims to acquire a high-throughput SPR instrument that meets specific technical requirements, including dimensions, weight, temperature ranges, and data collection capabilities, to facilitate biophysical and structural analysis of macromolecules. This equipment is critical for advancing research in infectious diseases and vaccine development. Interested vendors must submit their quotes by 4:30 PM EST on September 19, 2024, to Hershea Vance at hershea.vance@nih.gov, and ensure compliance with all specified requirements and clauses outlined in the solicitation documents.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    TUNABLE QUANTUM MID-IR CASCADE LASER SYSTEM
    Active
    Dept Of Defense
    The Department of Defense, specifically the Naval Research Laboratory, intends to award a sole source contract to Daylight Solutions Inc. for the procurement of a Tunable Quantum Mid-IR Cascade Laser System. This specialized equipment is critical for advanced measurement and control applications within the laboratory's research initiatives. The procurement will be conducted under Simplified Acquisition Procedures, with a total value not exceeding $250,000, and interested parties have 15 calendar days from the publication of this notice to express their interest and capability to compete. For further inquiries, Richard Key can be contacted via email at richard.a.key2.civ@us.navy.mil.
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Kidney Reagents for Luminex 3D Analyzer
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract for Kidney Reagents for the Luminex 3D Analyzer, specifically for the Kidney Transplant Clinic at The Walter Reed National Military Medical Center in Bethesda, Maryland. The procurement aims to secure molecular and serological reagents from One Lambda Inc. that are essential for transplant testing, ensuring compatibility and reducing the risk of organ rejection between donors and recipients. These reagents are critical as they have been validated by the American Society of Histocompatibility and Immunogenetics (ASHI) and are necessary for maintaining the accreditation of the Immunology Lab. Interested parties may express their interest and provide a capability statement to Barbara Sonnier at barbara.n.sonnier.civ@health.mil by September 24, 2024, at 10:00 PM EST.